What Researchers Did
The researchers looked at hospital records from 14 medical centers that have their own hyperbaric oxygen therapy (HBOT) facilities, and compared people with serious soft tissue infections who received HBOT with those who did not.
What They Found
In this observational database study of 1,583 necrotizing soft tissue infection cases, HBOT was associated with fewer deaths among the sickest patients (4% vs. 23%, p less than 0.01), but not in less severe groups. Only 117 cases (7%) were treated with HBOT. Across the three less severe illness classes, there was no difference between the HBOT and comparison groups in hospital stay, direct cost, complications, or death. In the extreme severity class, the HBOT group also had fewer complications (45% vs. 66%, p less than 0.01). In a multivariable analysis, patients who did not receive HBOT were less likely to survive their hospital stay (odds ratio 10.6; 95% CI 5.2-25.1). The authors concluded that HBOT was associated with a survival benefit at HBOT-capable centers.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study used a hospital database and diagnosis and procedure codes rather than randomly assigning treatment, and only a small share of cases received HBOT, so the groups may differ in ways the matching did not capture.